FrancophonIA/ELRC3.0 huggingface dataset:
English: In the event of a suspected overdose or inadvertent intravenous administration, the patient should be treated symptomatically, e.g. with acyclovir or other anti-viral agents (see section 4.4) and supportive measures instituted as required.
Danish: Patienten skal behandles symptomatisk i tilfælde af mistanke om overdosering eller utilsigtet intravenøs administration, for eksempel med acyclovir eller andre antivirale midler (se pkt.
English: ≤ 0.5 cm up to 0.1 mL
Danish: ≤ 0,5 cm op til 0,1 ml
English: • Accidental exposure of Healthcare Professionals (HCPs) to IMLYGIC
Danish: • Sundhedspersonales utilsigtede eksponering for IMLYGIC
English: If healthcare professionals are accidentally exposed to Imlygic, see sections 4.4 and 6.6.
Danish: Hvis sundhedspersonalet ved et uheld eksponeres for Imlygic, se pkt.
English: GRH0149v1
Danish: GRH0259DAv1
English: Figure 5.
Danish: Figur 5.
English: If you get any side effects, talk to your healthcare professional.
Danish: Hvis du oplever bivirkninger, bør du tale med din læge, sygeplejerske eller apoteket.
English: Median 2.8 months (Range: 1.2 to > 14.9 months)
Danish: (interval: 1,2 til > 14,9 mdr.)
English: Study Month
Danish: Studiets endemål
English: Maximum storage time for thawed Imlygic in syringe
Danish: Maksimal opbevaringstid for optøet Imlygic i sprøjte
English: Median 23.3 (95% CI: 19.5, 29.6) months
Danish: Median 23,3 (95% CI: 19,5; 29,6) mdr.
English: Table 7.
Danish: Tabel 7.
English: o Recommendation regarding the accidental transmission of IMLYGIC from patient to close contacts or HCPs: o Instruction on how to behave after administration/accidental transmission and how and how often the dressing has to be changed and who should not change the dressing; o Instructions to minimise the risk of exposure of blood and body fluids to close contacts for the duration of IMLYGIC treatment through 30 days after the last administration of IMLYGIC.
Danish: o Instruktioner til, hvordan man skal forholde sig efter administration/utilsigtet overførsel og til, hvordan og hvor ofte bandagen skal skiftes, og hvem der ikke må skifte bandagen; o Instruktioner til, hvordan man minimerer nære kontakters risiko for eksponering for blod og kropsvæsker i hele perioden med IMLYGIC-behandling og i 30 dage efter sidste administration af IMLYGIC.
English: Obstructive airway disorder
Danish: Obstruktiv luftvejssygdom
English: The vial cap is colour coded: 106 PFU/mL is light green and 108 PFU/mL is royal blue.
Danish: Hætteglassets låg har en farvekode: 106 PFU/ml er lysegrønt, og 108 PFU/ml er kongeblåt.
English: What you need to know before and during Imlygic treatment You will not be given Imlygic: - if you are allergic to talimogene laherparepvec or any of the other ingredients of this medicine
Danish: Du vil ikke få Imlygic: - hvis du er allergisk over for talimogen laherparepvec eller et af de øvrige indholdsstoffer i dette lægemiddel (angivet i afsnit 6).
English: Other medicines and Imlygic
Danish: Brug af anden medicin sammen med Imlygic
English: Keeping wounds clean and dressed can help prevent these types of infections.
Danish: Disse infektionstyper kan forebygges, hvis man holder sårene rene og har forbindinger på dem.
English: 2.9 months (95% CI: 2.8, 4.0) HR: 0.42; (95% CI: 0.32, 0.54)
Danish: (95% CI: 2,8; 4,0) HR: 0,42 (95% CI: 0,32; 0,54)
English: (vasculitis), inflammation of the lungs (pneumonitis), worsening scaling of the skin (worsening psoriasis), and inflammation of kidneys (glomerulonephritis)
Danish: (forværring af psoriasis) og betændelse i nyrerne (glomerulonefritis)
English: No viral activity was detected in samples of the occlusive dressings, oral mucosa, anogenital area, and suspected herpetic lesions.
Danish: Der blev ikke påvist virusaktivitet i prøver fra okklusionsforbindinger, mundslimhinden, det anogenitale område og læsioner, der mistænktes at være af herpetisk oprindelse.
English: Figure 2.
Danish: Figur 2.
English: 1 vial.
Danish: 1 hætteglas.
English: Second
Danish: Anden
English: The vial cap is colour coded: 106 (1 million) PFU/mL is light green and 108 (100 million) PFU/mL is royal blue.
Danish: Hætteglassets låg har en farvekode: 106 (1 million) PFU/ml er lysegrønt, og 108 (100 millioner) PFU/ml er kongeblåt.
English: Women of childbearing potential should be advised to use an effective method of contraception to prevent pregnancy during treatment with Imlygic.
Danish: Kvinder i den fertile alder skal anbefales at bruge en sikker kontraceptionsmetode for at forhindre graviditet under behandling med Imlygic.
English: Vascular disorders Common
Danish: Vaskulære sygdomme Almindelig
English: Musculoskeletal and connective tissue disorders Very common Myalgia, Arthralgia, Pain in extremity Common
Danish: Ikke almindelig Granulomatøs dermatitis Knogler, led, muskler og bindevæv Meget almindelig Myalgi, artralgi, smerter i ekstremitet Almindelig
English: Gently swirl.
Danish: Skvulpes forsigtigt.
English: Injection administration for subcutaneous lesions
Danish: Injektion af subkutane læsioner
English: Figure 4.
Danish: Figur 4.
English: Nervous system disorders Very common Headache Common
Danish: Meget almindelig Hovedpine Almindelig
English: Figure 6.
Danish: Figur 6.
English: • Obligation to conduct post-authorisation measures The MAH shall complete, within the stated timeframe, the below measures: Description
Danish: Indehaveren af markedsføringstilladelsen skal inden for den fastsatte tidsramme gennemføre følgende foranstaltninger:
English: Imlygic 108 plaque forming units (PFU)/mL solution for injection Semi-translucent to opaque liquid following thaw from its frozen state.
Danish: Imlygic 108 plaquedannende enheder (PFU)/ml injektionsvæske, opløsning Halvgennemsigtig til uigennemsigtig væske efter optøning fra frossen tilstand.
English: Figure 3.
Danish: Figur 3.
English: GRH0116v1
Danish: GRH03237DAv1
English: The safety and efficacy of Imlygic in paediatric patients has not been established.
Danish: Imlygics sikkerhed og virkning hos børn er ikke klarlagt.
English: Package leaflet: Information for the patient Imlygic 106 plaque forming units (PFU)/mL solution for injection Imlygic 108 plaque forming units (PFU)/mL solution for injection talimogene laherparepvec
Danish: Indlægsseddel: Information til patienten Imlygic 106 plaquedannende enheder (PFU)/ml injektionsvæske, opløsning Imlygic 108 plaquedannende enheder (PFU)/ml injektionsvæske, opløsning talimogen laherparepvec
English: Durable response rate Primary
Danish: Varig responsrate
English: Subsequent doses should be administered up to 4 mL of Imlygic at a concentration of 108 (100 million) PFU/mL.
Danish: Efterfølgende doser skal administreres med op til 4 ml Imlygic i en koncentration på 108 (100 millioner) PFU/ml.
English: Use a new needle anytime the needle is completely removed from a lesion and each time a different lesion is injected.
Danish: • Gentag disse trin for andre læsioner, der skal injiceres i. Brug en ny kanyle hver gang kanylen har været fjernet helt fra en læsion, og hver gang der skal injiceres i en anden læsion.
English: > 2.5 cm to 5 cm up to 2 mL
Danish: > 2,5 cm til 5 cm op til 2 ml
English: Imlygic 106 plaque forming units (PFU)/mL solution for injection Clear to semi-translucent liquid following thaw from its frozen state.
Danish: Imlygic 106 plaquedannende enheder (PFU)/ml injektionsvæske, opløsning Klar til halvgennemsigtig væske efter optøning fra frossen tilstand.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each vial contains 1 mL of 1 x 106 (1 million) plaque forming units (PFU) of talimogene laherparepvec.
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hvert hætteglas indeholder 1 ml af 1 x 106 (1 million) plaquedannende enheder (PFU) af talimogene laherparepvec.
English: Women of childbearing potential should be advised to use an effective method of contraception to prevent pregnancy during treatment with Imlygic (see section 4.6).
Danish: Kvinder i den fertile alder skal anbefales at bruge en sikker kontraceptionsmetode for at forhindre graviditet under behandling med Imlygic (se pkt.
English: Subsequent doses will be up to 4 mL of Imlygic at a concentration of 108 (100 million) PFU/mL.
Danish: De efterfølgende doser vil være op til 4 ml Imlygic i en koncentration på 108 (100 millioner) PFU/ml.
English: > 0.5 cm to 1.5 cm up to 0.5 mL
Danish: > 0,5 cm til 1,5 cm op til 0,5 ml
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each vial contains 1 mL of 1 x 108 (100 million) plaque forming units (PFU) of talimogene laherparepvec.
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hvert hætteglas indeholder 1 ml af 1 x 108 (100 millioner) plaquedannende enheder (PFU) af talimogene laherparepvec.
English: > 1.5 cm to 2.5 cm up to 1 mL
Danish: > 1,5 cm til 2,5 cm op til 1 ml
English: 4.1 months
Danish: 4,1 mdr.
English: If Imlygic is used during pregnancy, or if the patient becomes pregnant while taking Imlygic, the patient should be apprised of the potential hazards to the foetus and/or neonate.
Danish: Patienten skal informeres om den potentielle fare for fosteret og/eller det nyfødte barn, hvis Imlygic anvendes under graviditeten, eller hvis patienten bliver gravid, mens hun tager Imlygic.
English: • Muscle pain (myalgia), painful/swollen joints (arthralgia), limb pain
Danish: • Muskelsmerter (myalgi), ømme/hævede led (artralgi), smerter i ekstremiteter
English: 8.2 months (95% CI: 6.5, 9.9)
Danish: (95% CI: 6,5; 9,9)
English: Infectious talimogene laherparepvec virus was detected at the site of injection in 7 (11%) patients at multiple time points in the study; no samples were positive for viral infectivity after cycle 2 or after the end of treatment.
Danish: Der blev på flere tidspunkter under studiet påvist smitsom talimogen laherparepvec-virus på injektionsstedet hos 7 (11%) patienter.
English: Initial
Danish: Første
English: What Imlygic is and what it is used for What you need to know before and during Imlygic treatment How Imlygic is given
Danish: Det skal du vide, før og under behandling med Imlygic Sådan gives Imlygic
English: The initial recommended dose is up to a maximum of 4 mL of Imlygic at a concentration of 106 (1 million) PFU/mL.
Danish: Den anbefalede initialdosis er op til maksimalt 4 ml Imlygic i en koncentration på 106 (1 million) PFU/ml.
English: Imlygic 106 plaque forming units (PFU)/mL solution for injection Imlygic 108 plaque forming units (PFU)/mL solution for injection
Danish: Imlygic 106 plaquedannende enheder (PFU)/ml injektionsvæske, opløsning Imlygic 108 plaquedannende enheder (PFU)/ml injektionsvæske, opløsning
English: Malaise, Axillary pain
Danish: Utilpashed, smerter i aksiller
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Imlygic 106 PFU/mL injection talimogene laherparepvec
Danish: LÆGEMIDLETS NAVN, STYRKE OG/ELLER ADMINISTRATIONSVEJ(E) Imlygic 106 PFU/ml injektionsvæske talimogene laherparepvec
English: The initial recommended dose is up to 4 mL of Imlygic at a concentration of 106 (1 million) PFU/mL.
Danish: Den anbefalede startdosis er op til 4 ml Imlygic i en koncentration på 106 (1 million) PFU/ml.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Imlygic 108 PFU/mL injection talimogene laherparepvec
Danish: LÆGEMIDLETS NAVN, STYRKE OG/ELLER ADMINISTRATIONSVEJ(E) Imlygic 108 PFU/ml injektionsvæske talimogene laherparepvec
English: Infection and delayed healing at Imlygic injection site
Danish: Infektion og forsinket opheling på injektionsstedet for Imlygic Imlygic kan medføre infektion på injektionsstedet.
English: • Abdominal discomfort
Danish: • Generel utilpashed
English: • Thaw Imlygic vial(s) at room temperature.
Danish: • Optø hætteglasset (-glassene) med Imlygic ved stuetemperatur.
English: • Tissue swelling (peripheral oedema)
Danish: • Hævelse i væv (perifert ødem)
English: Post-injection
Danish: Efter injektion
English: Dyspnoea, Oropharyngeal pain, Upper respiratory tract infection
Danish: Dyspnø, orofaryngeale smerter, infektion i øvre luftveje Ikke almindelig Obstruktiv luftvejssygdom Mave-tarm-kanalen
English: Pre-injection
Danish: Før injektion
English: 106 (1 million) PFU/mL 108 (100 million) PFU/mL
Danish: 106 (1 million) PFU/ml
English: After thawing
Danish: Efter optøning
English: If they develop signs or symptoms of herpes infection, you should ask them to contact their healthcare professional.
Danish: Bed dem søge læge, hvis de får tegn eller symptomer på herpes-infektion.
English: Hepatic and renal impairment
Danish: Nedsat lever- og nyrefunktion
English: • Cough
Danish: • Hoste
English: NAME OF THE MEDICINAL PRODUCT Imlygic 106 plaque forming units (PFU)/mL solution for injection talimogene laherparepvec
Danish: Imlygic 106 plaquedannende enheder (PFU)/ml injektionsvæske, opløsning talimogene laherparepvec
English: NAME OF THE MEDICINAL PRODUCT Imlygic 108 plaque forming units (PFU)/mL solution for injection talimogene laherparepvec
Danish: Imlygic 108 plaquedannende enheder (PFU)/ml injektionsvæske, opløsning talimogene laherparepvec
English: • Side effects related to the immune system such as narrowing or blockage of blood vessels
Danish: • Bivirkninger, der er forbundet med immunsystemet, for eksempel indsnævring eller blokering af blodkar (vaskulitis), lungebetændelse (pneumonitis), forværring af afskalning i huden
English: Imlygic 108 plaque forming units (PFU)/mL solution for injection Each vial contains 1 mL deliverable volume of Imlygic at a nominal concentration of 1 x 108 (100 million) plaque forming units (PFU)/mL.
Danish: 2.2 Kvalitativ og kvantitativ sammensætning Imlygic 106 plaquedannende enheder (PFU)/ml injektionsvæske, opløsning Hvert hætteglas indeholder 1 ml udviklet volumen Imlygic i en nominel koncentration på 1 x 106 (1 million) plaquedannende enheder (PFU)/ml Imlygic 108 plaquedannende enheder (PFU)/ml injektionsvæske, opløsning Hvert hætteglas indeholder 1 ml udviklet volumen Imlygic i en nominel koncentration på 1 x 108 (100 millioner) plaquedannende enheder (PFU)/ml Hjælpestof(fer), som behandleren skal være opmærksom på Hver 4 ml dosis indeholder cirka 30 mg (1,3 mmol) natrium og 80 mg sorbitol.
English: Impaired healing at the injection site
Danish: Forringet opheling på injektionsstedet
English: Tabulated list of adverse reactions
Danish: Tabelinddelt liste over bivirkninger
English: Exterior of the occlusive dressing Oral mucosa
Danish: Ydersiden af okklusionsforbindingen Mundslimhinden
English: Plasmacytoma at injection site* Blood and lymphatic system disorders Very common Oedema peripheral Common
Danish: Tumorsmerter, inficeret neoplasme Ikke almindelig Plasmacytom på injektionsstedet* Blod og lymfesystem
English: Neoplasms benign, malignant and unspecified (including cysts and polyps) Common
Danish: Ikke almindelig Infektion på incisionsstedet Benigne, maligne og uspecificerede tumorer (inkl.
English: Tell your healthcare professional if you are taking, have recently taken or might take any other medicines, including medicines, such as acyclovir, to treat or prevent herpes infections.
Danish: Det gælder også medicin, der bruges til behandling eller forebyggelse af herpes-infektioner, for eksempel acyclovir.
English: Injection administration for cutaneous lesions
Danish: Injektion af kutane læsioner
English: Cardiac disorders Common
Danish: Hjerte Almindelig
English: *Monensin 32.4 g (equivalent to 35.2 g monensin sodium).
Danish: *Monensin 32,4 g (svarende til 35,2 g monensin natrium).
English: Invented name
Danish: Opfundet navn
English: EU Number
Danish: EU nummer
English: Strength Pharmaceutical form
Danish: Styrke Farmaceutisk formulering
English: Target species
Danish: Intendered e dyrearter
English: Packaging Content
Danish: Indgivelsesvej Emballage Indhold Pakning sstørrel se
English: Withdrawal period intraruminal device
Danish: Afvænningsp eriode
English: This summary was last updated in 08-2009.
Danish: Dette sammendrag blev sidst ajourført i 08-2009.
English: The marketing authorisation holder is Eli Lilly Nederland BV.
Danish: Indehaveren af markedsføringstilladelsen er Eli Lilly Nederland BV.
English: Ariclaim can be taken with or without food.
Danish: Ariclaim kan tages med eller uden et måltid.
English: If the treatment is effective, it should then be evaluated at least every three months.
Danish: Hvis behandlingen virker, bør den herefter vurderes mindst hver tredje måned.
English: Ariclaim duloxetine
Danish: Ariclaim duloxetin
English: The marketing authorisation was renewed on 11 August 2009.
Danish: Markedsføringstilladelsen blev fornyet den 11. august 2009.
English: Other information about Ariclaim:
Danish: Andre oplysninger om Ariclaim:
English: It is available as gastroresistant capsules (white and blue: 30 mg; green and blue: 60 mg).
Danish: Det leveres som gastroresistente kapsler (hvide og blå: 30 mg, grønne og blå: 60 mg).
English: The response to treatment should be assessed two months after starting treatment.
Danish: Behandlingsresponsen bør tages op til vurdering to måneder efter behandlingens start.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Ariclaim on 11 August 2004.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Ariclaim den 11. august 2004.
English: Neurotransmitters are chemicals that allow nerve cells to communicate with one another.
Danish: Neurotransmittere er kemiske stoffer, som sætter nervecellerne i stand til at kommunikere med hinanden.
English: Ariclaim was originally also authorised at strengths of 20 and 40 mg for the treatment of moderate to severe stress urinary incontinence (SUI) in women, but the company withdrew these strengths when the marketing authorisation was renewed in August 2009.
Danish: Ariclaim blev oprindeligt også godkendt i styrker på 20 og 40 mg til behandling af moderat til svær stressinkontinens (SUI) hos kvinder, men virksomheden fjernede disse styrker ved fornyelsen af markedsføringstilladelsen i august 2009.
English: This prevents the active substance being destroyed by the acid in the stomach.
Danish: Dette forhindrer det aktive stof i at blive ødelagt af mavesyren.
English: The recommended dose of Ariclaim is 60 mg once a day, but some patients may need a higher dose of 120 mg per day.
Danish: Den anbefalede dosis er 60 mg en gang dagligt, men nogle patienter kan have behov for en højere dosis på 120 mg dagligt.
English: Three different doses of Ariclaim were compared with placebo.
Danish: Tre forskellige doser Ariclaim blev sammenlignet med placebo.
English: Treatment must not be started in patients with uncontrolled high blood pressure, because of a risk of hypertensive crisis (sudden, dangerously high blood pressure).
Danish: Der må ikke indledes behandling af patienter med ukontrolleret højt blodtryk på grund af risikoen for hypertensive kriser (pludseligt, ekstremt højt blodtryk).
English: The dose should be reduced gradually when stopping treatment.
Danish: Dosis skal reduceres gradvis, når behandlingen afsluttes.
English: The full EPAR for Ariclaim is available here.
Danish: Den fuldstændige EPAR for Ariclaim findes her.
English: Ariclaim has been studied in two 12-week studies in 809 diabetic adults who had had pain every day for at least six months.
Danish: Ariclaim blev undersøgt i to 12-ugers undersøgelser med 809 voksne med diabetes, som havde haft smerter hver dag i de sidste seks måneder.
English: In both studies, pain reduction was seen from the first week of treatment for up to 12 weeks, with patients taking Ariclaim having pain scores between 1.17 and 1.45 points lower than those taking placebo.
Danish: I begge undersøgelserne kunne der iagttages en smertelindring fra den første uge af behandlingen i op til 12 uger hos patienter, som fik Ariclaim, hvor smertescorerne lå på mellem 1,17 og 1,45 point lavere end hos dem, der fik placebo.
English: The Committee for Medicinal Products for Human Use (CHMP) decided that Ariclaim's benefits are greater than its risks for the treatment of diabetic peripheral neuropathic pain in adults.
Danish: Udvalget for Humanmedicinske Lægemidler (CHMP) konkluderede, at fordelene ved Ariclaim er større end risiciene ved behandling af diabetiske perifere neuropatiske smerter hos voksne.
English: The main measure of effectiveness was the change in the severity of pain each week, as recorded by the patients on an 11-point scale in daily diaries.
Danish: Det vigtigste mål for virkningen var forandringer i sværhedsgraden af smerterne hver uge, således som patienterne registrerede disse på en 11-pointskala i dagskemaer.
English: ‘Gastroresistant' means that the capsules' contents pass through the stomach without being broken down until they reach the intestine.
Danish: ‘Gastroresistent' betyder, at kapslernes indhold passerer gennem maven og først bliver nedbrudt, når de når ned i tarmene.
English: The Committee recommended that Ariclaim be given marketing authorisation.
Danish: Udvalget anbefalede udstedelse af markedsføringstilladelse for Ariclaim.
English: Ariclaim is a medicine that contains the active substance duloxetine.
Danish: Ariclaim er et lægemiddel, som indeholder det aktive stof duloxetin.
English: Most of these were mild or moderate, starting early in treatment and getting milder as treatment continued.
Danish: De fleste af disse bivirkninger var milde til moderate og startede tidligt i behandlingen, men aftog efterhånden.
English: It must not be used together with monoamine oxidase inhibitors (a group of antidepressants), fluvoxamine (another antidepressant), or ciprofloxacin or enoxacin (types of antibiotic).
Danish: Det må ikke anvendes sammen med monoaminoxidasehæmmere (en gruppe af antidepressiva), fluvoxamin (et andet antidepressivum) eller ciprofloxacin eller enoxacin (former for antibiotika).
English: The most common side effects with Ariclaim (seen in more than 1 patient 10) are headache, somnolence (sleepiness), dizziness, nausea and dry mouth.
Danish: De mest almindelige bivirkninger ved Ariclaim (som ses hos flere end 1 ud af 10 patienter) er hovedpine, søvntrang, svimmelhed, kvalme og mundtørhed.
English: Ariclaim at doses of 60 mg once or twice a day was more effective at reducing pain than placebo.
Danish: Ariclaim var ved doser på 60 mg en eller to gange dagligt mere effektivt til at reducere smerter end placebo.
English: It works by preventing the neurotransmitters 5-hydroxytrypamine (also called serotonin) and noradrenaline from being taken back up into nerve cells in the brain and spinal cord.
Danish: Det virker ved at forhindre neurotransmitterne 5-hydroxytrypamin (også kaldet serotonin) og noradrenalin i at blive genoptaget i nerveceller i hjernen og rygmarven.
English: By blocking their re-uptake, duloxetine increases the amount of these neurotransmitters in the spaces between these nerve cells, increasing the level of communication between the cells.
Danish: Ved at blokere for genoptagelsen af disse stoffer øger duloxetin mængden af disse neurotransmittere i mellemrummene mellem nervecellerne og øger derved kommunikationen mellem disse celler.
English: Ariclaim is used to treat pain due to diabetic peripheral neuropathy (damage to the nerves in the extremities that can occur in patients with diabetes).
Danish: Ariclaim anvendes til behandling af smerter som følge af diabetisk perifer neuropati (beskadigelse af nerverne i ekstremiteterne, som kan forekomme hos patienter med diabetes).
English: What is the risk associated with Ariclaim?
Danish: Hvilken risiko er der forbundet med Ariclaim?
English: Since these neurotransmitters are involved in reducing the sensation of pain, blocking their re-uptake into nerve cells may improve the symptoms of neuropathic pain.
Danish: Da disse neurotransmittere medvirker til at nedsætte smertefornemmelsen, kan blokeringen af genoptagelsen af disse i nervecellerne forbedre de neuropatiske smertesymptomer.
English: SUI is accidental leaks of urine during physical exertion or when coughing, laughing, sneezing, lifting or exercising.
Danish: Stressinkontinens er utilsigtet tab af urin ved fysisk belastning eller i forbindelse med hoste, latter, nysen, løft eller fysiske øvelser.
English: The active substance in Ariclaim, duloxetine, is a serotonin-noradrenaline re-uptake inhibitor.
Danish: Det aktive stof i Ariclaim, duloxetin, er en selektiv serotonin-noradrenalin genoptagelseshæmmer.